Published in Natl Cancer Inst Monogr on March 01, 1977
Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice. Cancer Treat Rep (1976) 0.83
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Adv Exp Med Biol (1999) 0.81
[Neutron activation analysis in the pharmacokinetics of cis-dichlorodiammineplatinum (experimental studies)]. Med Radiol (Mosk) (1980) 0.81
[The cytotoxicity of Chamaenerium angustifolium (L.) Scop. and Hippophae rhamnoides L. tannins and their effect on mitochondrial respiration]. Eksp Klin Farmakol (1997) 0.75
[Effect of phenobarbital and SKF 525-A on the toxic and therapeutic action of adriamycin in mice with Ehrlich ascites cancer]. Eksp Onkol (1985) 0.75
[Changes in the activity of nonspecific liver oxidases after surgery for cancer in children]. Pediatriia (1982) 0.75
The rate of cyclophosphamide activation. Neoplasma (1970) 0.75
[Reducing of hepatotoxicity of antineoplastic chemotherapy and concomitant viral infection through control of liver metabolism: from experiment to clinical practice]. Vopr Onkol (2001) 0.75
[Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use]. Antibiotiki (1976) 0.75
[Radiobiological analysis of the antineoplastic action of sarcolysine]. Med Radiol (Mosk) (1982) 0.75
[The trypanocidal action of fluorouracil on Crithidia oncopelti in the presence of lipid metabolic modifiers]. Izv Akad Nauk SSSR Biol (1992) 0.75
[Time factor in evaluating antineoplastic agents]. Farmakol Toksikol (1972) 0.75
[Activity of nonspecific hepatic oxidases and the biological effects of the antineoplastic antibiotic adriamycin]. Biull Eksp Biol Med (1981) 0.75
Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs. Oncology (1980) 0.75
[The drop in toxicity and the rise in the effectiveness of antineoplastic chemotherapy by correcting the activity of liver monooxygenases: from the experiment to the clinical practice]. Vestn Ross Akad Med Nauk (2002) 0.75
[Toxicity and cumulative properties of actinomycins C1, C2 and C3, contained in preparations in various combinations]. Antibiotiki (1971) 0.75
[Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)]. Vestn Akad Med Nauk SSSR (1984) 0.75
[Antineoplastic and toxic effects of blastolysin in the treatment of spontaneous mammary cancer in dogs]. Eksp Onkol (1984) 0.75
The treatment of hypertrophy of the prostate of rats with 4-nitro-3-trifluoromethylisobutyranilide (Sch 13521). Arzneimittelforschung (1977) 0.75
[Effect of herbicides--derivatives of chlorphenoxyacetic acid on human and animal organism. (Literature review)]. Farmakol Toksikol (1970) 0.75
[Activity of hepatic nonspecific oxidases and the biological effects of antitumor preparations]. Vestn Akad Med Nauk SSSR (1981) 0.75
[The experimental chemotherapy of malignant tumors today]. Vopr Onkol (1995) 0.75
[Antineoplastic and immunodepressive activity of purinylglutathionyl disulfide]. Farmakol Toksikol (1972) 0.75
[Effect of sarcolysin and embikhin on neutral red sorption by some organs and tumors in rats]. Farmakol Toksikol (1970) 0.75
Design of cancer chemotherapy: tailored sensitivity assays. Antibiot Chemother (1971) (1980) 0.75
[New concepts of microsomal metabolism of the antibiotic adriamycin]. Bioorg Khim (1985) 0.75
[The effect of calcium gluconate on the acute and chronic toxicity of doxorubicin in mice]. Antibiot Khimioter (1997) 0.75
[Antineoplastic effect of asalin and asaleĭ during multiple and single enteral, intramuscular and rectal administration]. Farmakol Toksikol (1972) 0.75
[The biochemical mechanisms of the action of N-alkyl-N-nitrosoureas. The possible reasons for drug resistance to these compounds]. Eksp Klin Farmakol (1996) 0.75
[Obtaining and study of asalei and asalin suspensions]. Farmatsiia (1971) 0.75
[Regression of rat sarcoma 45 at single administration of sarcolysine, asalin and asalei]. Farmakol Toksikol (1970) 0.75
[Enhancement of antineoplastic activity of sarcolysin by the means of transforming it into lipid derivative and incorporating into liposomal membranes containing carbohydrate vector]. Biull Eksp Biol Med (1997) 0.75
[The effect of different antitumor preparations on the growth of a culture of the protozoan Crithidia oncopelti]. Izv Akad Nauk SSSR Biol (1989) 0.75
[ICO-166 monoclonal antibodies against the CD45RA antigen]. Biull Eksp Biol Med (1993) 0.75
[Effect of the induction and inhibition of liver monooxygenases on the toxic and therapeutic action of vincristine]. Antibiot Med Biotekhnol (1986) 0.75
[Ways to overcome the contradictions between the experimental and clinical chemotherapy of tumors]. Vopr Onkol (1990) 0.75
[Dynamics of toxic manifestations and antineoplastic effect of dactinomycin after single-dose administration]. Antibiotiki (1971) 0.75
[Development of substances for active prevention of cancer based on vitamins and preventive-treatment products]. Vopr Med Khim (1993) 0.75
[Blastolysin, an agent potentiating the antitumor action of ionizing radiation]. Dokl Akad Nauk SSSR (1980) 0.75
[Antitumor and toxic effects of amotin]. Eksp Onkol (1987) 0.75
[Role of immunity in the action of sarcolysine and other preparations]. Vestn Akad Med Nauk SSSR (1971) 0.75
[Development of oncological research performed at the dissertation level 1976-1980]. Vopr Onkol (1983) 0.75
[Effect of calcium gluconate on the toxicity and antitumor of doxorubicin in mice]. Antibiot Khimioter (1999) 0.75
[Some pharmacological properties of fluorodopan]. Farmakol Toksikol (1971) 0.75
[Comparative study of the effect of zixoryn and phenobarbital on the toxicity of anthracycline antibiotics and liver monooxygenase activity in mice]. Vestn Akad Med Nauk SSSR (1985) 0.75
[Potentiation by blastolysin of the effect of cyclophosphamide in preventing recurrence in mouse T-cell leukemia]. Biull Eksp Biol Med (1984) 0.75
[A study of the antitumor effectiveness of endoxan when administered in various ways]. Vopr Onkol (1969) 0.75
[Dextran-ferrite distribution in the body of animals in a nonuniform permanent magnetic field]. Eksp Onkol (1990) 0.75
[Mitigation of cisplatin toxicity by the complexon tetacin-calcium]. Eksp Onkol (1985) 0.75
[The preclinical assessment of the activity and pharmacological action of native human interleukin-2]. Patol Fiziol Eksp Ter (1990) 0.75
[The effect of topoisomerase II inhibitor, vepesid, on binding of doxorubicin with DNA in tumor cells sensitive to anthracycline]. Biull Eksp Biol Med (1997) 0.75
[Toxicity of N-acetylsarcolysin peptides following diverse routes of administration]. Farmakol Toksikol (1972) 0.75
[Lifetime quantitative assessment of intracellular distribution of doxorubicin in tumor cells]. Biull Eksp Biol Med (1995) 0.75
[Toxicological properties of fentirin]. Farmakol Toksikol (1980) 0.75
[Pharmacological properties of 20 antibiotic isolated from Aspergillus fumigatus]. Antibiotiki (1969) 0.75
[Analysis of dissertations on antineoplastic chemotherapy presented 1981-1985]. Vopr Onkol (1988) 0.75
[Antidotal and antineoplastic properties of copper sulfate]. Biull Eksp Biol Med (1988) 0.75
[Effect of 5-fluorouracil on food requirement, body and organ growth in rats]. Farmakol Toksikol (1969) 0.75